AACC and NACB Present: Glycemic Control in the Hospital: Evidence, Issues and Future Directions

Banner Image

29th Arnold O. Beckman Conference
April 12-13, 2011
OMNI San Diego Hotel, San Diego, CA

Banner Image

AACC and NACB will present the next Arnold O. Beckman Conference “Glycemic Control in the Hospital: Evidence, Issues, and Future Directions”, on April 12 and 13, 2011 in San Diego.  The conference will be held in conjunction with the 2011 Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE).

In addition to the AACE, several key stakeholder organizations are involved in the conference planning and development efforts: American Diabetes Association, College of American Pathologists, Clinical and Laboratory Standards Institute, and the Society for Critical Care Medicine. The AACC’s Critical and Point of Care Division is also participating in this conference.

The planning committee, led by Drs. Steve Kahn (Chair) and Rob Christenson (Vice Chair), are inviting an esteemed group of individuals to speak, including Dr. Greet Van den Berghe, who will discuss the landmark Belgian study on the effects of intensive insulin treatment on critically ill patients.

There will be additional presentations on the various perspectives on tight, moderate, and intensive glycemic control, as well as several talks on important clinical and analytical issues (including glucose meter issues). The conference will conclude with thoughts and recommendations from the experts on future strategies for glycemic control.

To learn more and to register, visit the conference website.

Target audience
Clinical endocrinologists, critical care physicians, pathologists, hospitalists, laboratorians, nurses, point-of-care coordinators, diabetes educators, industry representatives, regulatory affairs specialists, fellows/residents, and others involved with glycemic control in the hospital setting.

Conference Learning Objectives
After participating in this conference, participants should be able to:

  • Describe varying perspectives on glycemic control, based on presented evidence from significant studies.
  • Explain the analytical and clinical issues surrounding the use of glucose meters in glycemic control.
  • Suggest strategies on implementing protocols for glycemic control in hospitalized patients, resulting in improved outcomes.
  • Initiate discussions about glycemic control to foster a dialogue and exchange of information between health care disciplines.

Tuesday, April 12, 2011

Welcome and Opening remarks

Session #1: Evidence (Perspectives on glycemic control)

  • Belgium studies
  • Portland protocol results
  • NICE sugar study
  • Benefits and risks of glycemic control: Metanalysis
  • Panel discussion and Q&A

Session #2: Issues (Clinical and laboratory medicine issues, including glucose meters)

  • Patient safety issues and glycemic control
  • Clinical presentation on the management and risks of hypoglycemia
  • Interferences with glucose meter testing
  • Are glucose meters up to the task of TGC?
  • Predicted discrepancies between direct reading whole blood biosensors and central lab plasma methods
  • Panel discussion and Q&A

Wednesday, April 13, 2011

Session #3: Future Directions (Key issues, focusing on future directions)

  • FDA perspective on glycemic control and glucose meters
  • Current status of laboratory practice guidelines on glucose meter use
  • Tighter Performance Criteria: Achievable and Appropriate
  • Panel Discussion and Q&A
  • Use of insulin dosing software and algorithms
  • Continuous glucose monitoring
  • Future strategies and paradigms for glycemic control
  • Panel Discussion and Q&A

Closing remarks

Page Access: